| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Canada | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | United States | 2 | |
| #5 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Enzymes | |
| #5 | Analysing materials | |
| #6 | Measuring microorganism processes | |
| #7 | Peptides | |
| #8 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Radding Jeffrey A | 5 |
| #2 | Joseph-Mccarthy Diane M | 4 |
| #3 | Ferullo Daniel J | 4 |
| #4 | Koeva Martina I | 3 |
| #5 | Joseph-Mccarthy Diane | 2 |
| #6 | Radding Jeffrey | 1 |
| #7 | Koeva Martina | 1 |
| #8 | Bermudez Luiz | 1 |
| #9 | Koeva Martin I | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020252462A1 | Antibiotic potentiation for nontuberculous mycobacterial disease | |
| WO2018126108A1 | Bacteriophage having modified recognition baseplate protein structural domains | |
| CA3046085A1 | Aminoglycoside potentiation for treatment of pulmonary bacterial infection | |
| WO2018035407A1 | Bacteriophages for neutralizing toxins and methods of use thereof | |
| EP3324987A1 | Bacteriophage for treating staphylococcus infections |